241 related articles for article (PubMed ID: 25895128)
1. CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.
Ganghammer S; Hutterer E; Hinterseer E; Brachtl G; Asslaber D; Krenn PW; Girbl T; Berghammer P; Geisberger R; Egle A; Zucchetto A; Kruschinski A; Gattei V; Chigaev A; Greil R; Hartmann TN
Oncotarget; 2015 May; 6(14):12048-60. PubMed ID: 25895128
[TBL] [Abstract][Full Text] [Related]
2. Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis.
O'Hayre M; Salanga CL; Kipps TJ; Messmer D; Dorrestein PC; Handel TM
PLoS One; 2010 Jul; 5(7):e11716. PubMed ID: 20661426
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia.
Cui XY; Tjønnfjord GE; Kanse SM; Dahm AEA; Iversen N; Myklebust CF; Sun L; Jiang ZX; Ueland T; Campbell JJ; Ho M; Sandset PM
Sci Rep; 2021 Mar; 11(1):5127. PubMed ID: 33664415
[TBL] [Abstract][Full Text] [Related]
4. Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.
Kashyap MK; Amaya-Chanaga CI; Kumar D; Simmons B; Huser N; Gu Y; Hallin M; Lindquist K; Yafawi R; Choi MY; Amine AA; Rassenti LZ; Zhang C; Liu SH; Smeal T; Fantin VR; Kipps TJ; Pernasetti F; Castro JE
J Hematol Oncol; 2017 May; 10(1):112. PubMed ID: 28526063
[TBL] [Abstract][Full Text] [Related]
5. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL).
Richardson SJ; Matthews C; Catherwood MA; Alexander HD; Carey BS; Farrugia J; Gardiner A; Mould S; Oscier D; Copplestone JA; Prentice AG
Blood; 2006 May; 107(9):3584-92. PubMed ID: 16332969
[TBL] [Abstract][Full Text] [Related]
6. BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.
Haerzschel A; Catusse J; Hutterer E; Paunovic M; Zirlik K; Eibel H; Krenn PW; Hartmann TN; Burger M
Ann Hematol; 2016 Dec; 95(12):1979-1988. PubMed ID: 27542958
[TBL] [Abstract][Full Text] [Related]
7. JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia.
Montresor A; Toffali L; Mirenda M; Rigo A; Vinante F; Laudanna C
Oncotarget; 2015 Oct; 6(33):34245-57. PubMed ID: 26413812
[TBL] [Abstract][Full Text] [Related]
8. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.
Burger M; Hartmann T; Krome M; Rawluk J; Tamamura H; Fujii N; Kipps TJ; Burger JA
Blood; 2005 Sep; 106(5):1824-30. PubMed ID: 15905192
[TBL] [Abstract][Full Text] [Related]
9. Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway.
Kashyap MK; Kumar D; Jones H; Amaya-Chanaga CI; Choi MY; Melo-Cardenas J; Ale-Ali A; Kuhne MR; Sabbatini P; Cohen LJ; Shelat SG; Rassenti LZ; Kipps TJ; Cardarelli PM; Castro JE
Oncotarget; 2016 Jan; 7(3):2809-22. PubMed ID: 26646452
[TBL] [Abstract][Full Text] [Related]
10. Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis.
Pavlasova G; Borsky M; Seda V; Cerna K; Osickova J; Doubek M; Mayer J; Calogero R; Trbusek M; Pospisilova S; Davids MS; Kipps TJ; Brown JR; Mraz M
Blood; 2016 Sep; 128(12):1609-13. PubMed ID: 27480113
[TBL] [Abstract][Full Text] [Related]
11. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
[TBL] [Abstract][Full Text] [Related]
12. Role of chemokines and their receptors in chronic lymphocytic leukemia: function in microenvironment and targeted therapy.
Han TT; Fan L; Li JY; Xu W
Cancer Biol Ther; 2014 Jan; 15(1):3-9. PubMed ID: 24149438
[TBL] [Abstract][Full Text] [Related]
13. The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization.
Hoellenriegel J; Zboralski D; Maasch C; Rosin NY; Wierda WG; Keating MJ; Kruschinski A; Burger JA
Blood; 2014 Feb; 123(7):1032-9. PubMed ID: 24277076
[TBL] [Abstract][Full Text] [Related]
14. PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).
Decker S; Finter J; Forde AJ; Kissel S; Schwaller J; Mack TS; Kuhn A; Gray N; Follo M; Jumaa H; Burger M; Zirlik K; Pfeifer D; Miduturu CV; Eibel H; Veelken H; Dierks C
Mol Cancer Ther; 2014 May; 13(5):1231-45. PubMed ID: 24659821
[TBL] [Abstract][Full Text] [Related]
15. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.
López-Giral S; Quintana NE; Cabrerizo M; Alfonso-Pérez M; Sala-Valdés M; De Soria VG; Fernández-Rañada JM; Fernández-Ruiz E; Muñoz C
J Leukoc Biol; 2004 Aug; 76(2):462-71. PubMed ID: 15155773
[TBL] [Abstract][Full Text] [Related]
16. ZAP70 expression enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest by valency regulation of integrins.
Laufer JM; Lyck R; Legler DF
FASEB J; 2018 Sep; 32(9):4824-4835. PubMed ID: 29589978
[TBL] [Abstract][Full Text] [Related]
17. In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironment.
Kriston C; Plander M; Márk Á; Sebestyén A; Bugyik E; Matolcsy A; Barna G
Ann Hematol; 2018 Nov; 97(11):2145-2152. PubMed ID: 29955944
[TBL] [Abstract][Full Text] [Related]
18. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
[TBL] [Abstract][Full Text] [Related]
19. CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease.
Barretina J; Juncà J; Llano A; Gutiérrez A; Flores A; Blanco J; Clotet B; Esté JA
Ann Hematol; 2003 Aug; 82(8):500-505. PubMed ID: 12783211
[TBL] [Abstract][Full Text] [Related]
20. CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells.
Vaisitti T; Aydin S; Rossi D; Cottino F; Bergui L; D'Arena G; Bonello L; Horenstein AL; Brennan P; Pepper C; Gaidano G; Malavasi F; Deaglio S
Leukemia; 2010 May; 24(5):958-69. PubMed ID: 20220774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
